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MORTALITY	 OF	 MIDLIFE	 WOMEN	 WITH	 SURGICALLY	 VERIFIED	
ENDOMETRIOSIS	 –	 A	 COHORT	 STUDY	 INCLUDING	 2.5	 MILLION	 PERSON-
YEARS	OF	OBSERVATION		
Study	question:	Is	the	all-cause	and	cause-specific	mortality	increased	among	women	with	surgically	verified	endometriosis?	
Summary	answer:		The	all-cause	and	cause-specific	mortality	in	midlife	was	lower	throughout	the	follow-up	among	women	with	surgically	verified	endometriosis	compared	to	the	reference	cohort.		
What	is	known	already:	Endometriosis	has	been	associated	with	an	increased	risk	of	comorbidities	such	as	certain	cancers	and	cardiovascular	diseases.	These	diseases	are	also	common	causes	of	death	however,	little	is	known	about	the	mortality	of	women	with	endometriosis.	
Study	design,	size,	duration:	A	nationwide	retrospective	cohort	study	of	women	with	surgically	verified	diagnosis	of	endometriosis	compared	to	the	reference	cohort	in	Finland	(1987-2012).	Follow-up	ended	at	death	or	December	31st,	2014.	During	the	median	follow-up	of	17	years,	2.5	million	person-years	accumulated.		
Participants/materials,	setting,	methods:		49	956	women	with	at	least	one	record	of	surgically	verified	diagnosis	of	endometriosis	in	the	Finnish	Hospital	Discharge	Register	between	1987	and	2012	compared	to	a	reference	cohort	of	98	824	age-	and	municipality-matched	women.		The	age	(mean±SD)	of	the	endometriosis	cohort	was	36.4±9.0	and	53.6±12.1	years	at	the	beginning	and	the	end	of	the	follow-up.	By	using	the	Poisson	regression	models	the	crude	and	adjusted	all-cause	and	cause-specific	
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mortality	rate	ratios	(MRR)	and	95%	confidence	intervals	(CI)	were	assessed.	Calendar	time,	age,	time	since	the	start	of	follow-up,	educational	level,	and	parity	adjusted	were	considered	in	the	multivariate	analyses.				
Main	results	and	the	role	of	chance:	1656	and	4291	deaths	occurred	in	the	endometriosis	and	reference	cohorts,	respectively.	A	lower	all-cause	mortality	was	observed	for	the	endometriosis	cohort	(adjusted	MRR	0.73	[95%	CI	0.69	to	0.77])	-	there	were	four	deaths	less	per	1000	women	over	ten	years.	A	lower	cause-specific	mortality	contributed	to	this:	the	adjusted	MRR	was	0.88	(95%	CI	0.81	to	0.96)	for	any	cancer;	and	0.55	(95%	CI	0.47	to	0.65)	for	cardiovascular	diseases,	including	0.52	(95%	CI	0.42	to	0.64)	for	ischemic	heart	disease	and	0.60	(95%	CI	0.47	to	0.76)	for	cerebrovascular	disease.	Mortality	due	to	alcohol,	accidents	and	violence,	respiratory,	and	digestive	disease	related	causes	was	also	decreased.		
Limitations,	reasons	for	causation:		These	results	limit	to	the	women	with	endometriosis	diagnosed	in	a	surgery.	In	addition,	the	study	does	not	extend	into	the	oldest	age-groups.		The	results	might	be	explained	by	the	characteristics	and	factors	related	to	women’s	lifestyle,	and/or	increased	medical	attention	and	care	received,	rather	than	the	disease	itself.	
Wider	implications	of	the	findings:		These	reassuring	data	are	valuable	to	women	with	endometriosis	and	to	their	health	care	providers.	Nonetheless,	more	studies	are	needed	to	address	the	causality.		
Study	funding/competing	interest:	
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This	research	was	funded	by	the	Hospital	District	of	Helsinki	and	Uusimaa	and	The	Finnish	Medical	 Foundation.	 None	 of	 the	 authors	 report	 competing	 interest	 in	relation	to	the	present	work,	all	the	authors	have	completed	the	disclosure	form.			 	
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INTRODUCTION		Endometriosis	is	a	chronic	inflammatory	disease	affecting	approximately	5	to	10%	of	fertile-aged	women.	It	causes	substantial	individual	and	societal	burden,	comparable	to	other	chronic	diseases	(Simoens,	et	al.,	2012,	Vercellini,	et	al.,	2014).	Chronic	inflammation	is	linked	to	various	adverse	health	outcomes,	such	as	increased	risk	of	cardiovascular	disease,	cancer,	and	neurodegenerative	diseases	such	as	Alzheimer’s	disease	(Nogueira,	et	al.,	2015).			Indeed,	endometriosis	has	been	linked	to	increased	risk	of	several	associated	conditions,	including	malignant,	autoimmune,	rheumatoid,	and	cardiovascular	diseases.	There	is	also	an	increased	risk	of	several	cancers,	especially	endometrioid	and	clear	cell	types	of	ovarian	cancers	and	less	clearly	that	of	melanoma,	non-Hodgkin	lymphoma	and	thyroid	carcinoma	(Kvaskoff,	et	al.,	2015).		The	Nurse’s	Health	study	recently	found	that	the	risk	of	coronary	heart	disease	is	significantly	increased	(1.5	to	2	-fold)	among	women	with	laparoscopically	diagnosed	endometriosis.	In	addition	to	chronic	inflammation,	surgical	and/or	medical	treatments	of	endometriosis	may	contribute	to	this	increased	risk	(Mu,	et	al.,	2016).			Ischemic	heart	disease	has	long	been	the	leading	cause	of	death	worldwide,	and	cancer	is	the	leading	cause	of	death	in	younger	women	in	the	western	world	(Lozano,	et	al.,	2012,	Naghavi,	et	al.,	2017).	In	the	present	study,	we	examined	the	risk	of	death	in	a	large	cohort	of	women	with	surgically	verified	endometriosis	in	comparison	to	age	and	municipality	matched	reference	women	using	high	
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quality	Finnish	administrative	and	health	registers	(Gissler	and	Haukka,	2004,	Pukkala,	et	al.,	2018,	Sund,	2012).	There	is	only	one	previous	Swedish	study	assessing	cancer	survival	in	women	with	endometriosis	(Melin,	et	al.,	2011).		
	
MATERIALS	AND	METHODS		
Study	population	
	To	identify	surgically	diagnosed	cases,	all	endometriosis-associated	diagnoses	(International	Classification	of	Diseases	version	9	[ICD-9	1987-1995]:	6171A,	6172A,	6173A,	6173B,	6174A,	6175A,	6176A,	6178X,	6179X;	version	10	[ICD-10	1996-2012]:	N80.1-N80.6,	N80.8,	N80.80,	N80.81,	N80.89,	N80.9),	as	the	main	or	subsidiary	diagnosis,	in	combination	with	relevant	concomitant	surgical	codes	from	1987	to	2012	(n=49	956),	were	identified	from	the	Finnish	Hospital	Discharge	Register.		The	managing	clinician	sets	the	primary	and	secondary	ICD	codes	for	each	procedure	according	to	their	clinical	relevance.	Adenomyosis	as	a	sole	diagnosis	was	not	included.		The	index	day	was	set	to	the	day	of	discharge	from	the	first	hospital	episode	fulfilling	the	definition	of	surgically	verified	endometriosis.			There	were	altogether	57	713	endometriosis	diagnoses	among	49	956	women	in	the	index	procedure.	Peritoneal	endometriosis	was	the	most	common	diagnosis	(n=26	299,	46%)	followed	by	ovarian	endometriosis	(n=24	343,	42%),	other	or	
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unknown	endometriosis	(n=3578,	6%)	and	deep	infiltrating	endometriosis	(n=3493,	6%).			The	reference	cohort	(n=98	824)	was	randomly	drawn	by	a	computer	from	the	Finnish	Population	Information	System.	The	reference	cohort	was	first	constructed	by	selecting,	for	each	endometriosis	patient,	two	women	who	were	alive,	lived	in	the	same	municipality	and	were	of	similar	age	on	the	index	date,	and	had	no	surgically	verified	endometriosis	according	to	the	Finnish	Hospital	Discharge	Register	records	over	the	period	of	1987-2012	and	no	hospital	admissions	due	to	endometriosis	1983-1987.	The	final	reference	cohort	included	one	to	two	women	for	each	endometriosis	patient	fulfilling	these	criteria.			
	
Data	sources	
	In	Finland	administrative	and	health	data	for	the	entire	population	has	been	collected	for	decades	using	well	established	and	high	standard	procedures	(Gissler	and	Haukka,	2004,	Pukkala,	et	al.,	2017,	Sund,	2012).	A	unique	personal	identity	code,	issued	to	every	resident	in	Finland	since	1964-1968,	secures	a	reliable	data	recording	and	allows	data	linkage	since	1969.			The	Finnish	Hospital	Discharge	Register	(FHDR)	includes	personal	identity	codes,	codes	of	diseases	according	to	the	ICD,	and	dates	for	each	hospital	visit	since	1967	from	both	general	and	private	sector	inpatients,	as	well	as	for	day-surgeries	from	1994	onwards	(www.thl.fi/en/web/thlfi-en).	Validity	of	the	different	diseases	in	the	FHDR	has	been	evaluated	as	satisfactory	to	good	in	
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numerous	studies.	The	quality	assessment	of	FHDR	concerning	the	present	cohort	was	performed	prior	to	initiating	this	study	(Saavalainen,	et	al.,	2018).	
The	Finnish	Population	Information	System,	maintained	by	the	Finnish	Population	Register	Centre,	is	a	computerized	national	register	that	contains	basic	information	on	permanent	residents,	such	as	date	of	birth	and	death,	address,	and	biological	children	of	permanent	residents	(www.vrk.fi/en/frontpage).	
Statistics	Finland	is	a	public	authority	that	collects	and	maintains	administrative	data,	such	as	the	population	census	and	the	Cause-of-Death	Register	(www.stat.fi/index_en.html).	The	latter	includes	the	date	of	death	and	underlying	cause	of	death	according	to	the	disease	or	circumstance	(accident,	act	of	violence)	leading	to	death.	The	cause	of	death	is	determined	according	to	the	rules	of	the	ICD-10	compiled	by	the	World	Health	Organization.	The	causes-of-death	are	given	by	the	treating	physician	and	controlled	regionally	and	at	Statistics	Finland.		
Cohort	characteristics	
The	demographic	characteristics	of	the	whole	study	population	(n=148	780)	were	obtained	from	Statistics	Finland.	The	population	census	data	contains	data	on	socioeconomic	status,	education,	and	profession.	Because	the	data	on	occupation	and	socioeconomic	status	were	limited	to	the	census	years	(1995,	2000,	and	2004-2012)	only,	we	used	the	highest	educational	level	from	the	2014	
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census	as	a	proxy	for	socioeconomic	status.		In	the	analysis,	the	highest	education	level	reached	was	treated	as	a	categorical	variable	with	four	categories:	academic	degree	(bachelor,	master,	and	doctoral);	tertiary	(short-cycle	tertiary);	upper	secondary;	and	primary	(primary	and	unknown).			
The	baseline	calendar	time,	removal	of	gynecological	organs,	and	parity	status	were	represented	as	dichotomous	variables.	The	baseline	calendar	time	was	divided	into	two	periods	according	to	the	ICD	coding	system	(ICD-9	in	1987-1995,	and	ICD-10	in	1996-2012).		Based	on	the	data	on	removal	of	the	gynecological	organs	from	the	Finnish	Hospital	Discharge	Register	(1983-2012),	we	identified	those	with	any	gynecological	organ	removed	before	or	at	the	index	procedure.	The	baseline	parity	status	was	defined	according	to	the	information	on	live	births	obtained	from	the	Population	Register	as	at	least	one	live	birth	before	or	at	the	index	date	and	was	then	updated	according	to	the	follow-up	information.	
	
Follow-up	and	outcomes	of	interest	
	
Women	were	followed	from	the	index	day	until	death	or	until	the	end	of	follow-up	on	December	31st,	2014,	which	ever	came	first.	The	outcome	of	interest	was	the	mortality	from	any	cause,	as	well	as	the	cause-specific	mortality	based	on	the	underlying	cause	of	death.	The	specific	causes	of	death	were	studied	in	groups	formed	according	to	the	54-group	short-list	of	causes	
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of	death	by	Statistics	Finland	(Supplementary	Table	SI)	where	the	alcohol-related	deaths	are	separately	presented	as	their	incidence	in	Finland	is	high.		
	
Statistical	analysis	
	
For	each	outcome	of	interest,	the	crude	mortality	rate	was	calculated	as	the	number	of	deaths	divided	by	person	time	at	risk,	and	the	exact	95%	confidence	intervals	(CIs)	were	assessed	based	on	Poisson	rates.	For	any	cause	mortality,	we	assessed	both	crude	absolute	and	relative	rate	differences	(ratio)	in	mortality	rate	between	the	cohorts.	To	allow	for	assessment	of	time-varying	covariates,	such	as	age,	time	since	the	index	date,	and	parity,	the	individual	follow-up	time	was	split	into	the	smaller	bands.	We	calculated	adjusted	all-cause	and	cause-specific	mortality	rate	ratios	(MRRs)	with	95%	CIs	by	using	multivariate	Poisson	model.	We	controlled	for	age	and	time	since	the	index	day	as	modelled	by	spline	functions,	the	highest	educational	level	and	baseline	calendar	time	(Model	1),	and	further	for	parity	as	assessed	in	a	time-dependent	manner	(Model	2).	The	area	of	residence	at	the	time	of	first	endometriosis	surgery	was	not	statistically	significant	and	therefore	was	not	included.	To	study	the	changes	in	the	all-cause	MRRs	during	the	follow-up,	we	plotted	the	adjusted	MRR	with	95%	CI	from	the	Model	2	along	the	time	since	the	index	date.		In	addition,	we	used	the	(multivariate)	Poisson	model	with	identity	link	to	calculate	the	crude	(adjusted)	absolute	rate	differences	with	their	95%	CIs	for	death	from	all-causes	and	major	specific	causes.	
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We	performed	several	sensitivity	analyses.	To	check	whether	the	results	were	similar	across	all	ages	at	death	we	calculated	and	plotted	age-specific	MRRs	with	95%	CIs	for	the	all-cause	mortality	by	six	age	groups	(<30,	30-39,	40-49,	50-59,	60-69,	and	≥70	years	at	death).	To	assess	the	potential	heterogeneity	in	the	MRRs	according	to	the	baseline	gynecological	organ	removal	in	women	with	surgically	verified	endometriosis,	we	divided	the	endometriosis	cohort	into	two	groups,	those	with	and	without	the	baseline	gynecological	organ	removal.		By	substituting	the	binary	variable	for	endometriosis	(no/yes)	in	Model	2	by	a	variable	with	three	categories	(no/yes	without	removal/yes	with	removal),	we	compared	the	endometriosis	subgroups	to	the	reference	cohort,	from	which	we	excluded	women	who	had	undergone	gynecological	organ	removal	before	beginning	of	the	follow-up.		
We	set	statistical	significance	level	at	5%	and	considered	the	results	with	p-values	<	0.05	as	statistically	significant.	All	statistical	analyses	were	performed	using	R	statistical	software	version	3.5.0	(www.r-project.org),	with	the	Epi-package	for	splitting	the	individual	follow-up	(Plummer	and	Carstensen,	2011),	and	the	Forestplot-package	for	the	graphical	output	(Gordon	and	Lumney,	2017).	
	
Ethical	approval		Before	initiation	this	study	was	approved	by	the	ethics	committee	of	the	Hospital	District	of	Helsinki	and	Uusimaa	(238/13/03/03/2013).		Permissions	to	utilize	
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the	data	and	to	perform	the	linkages	were	provided	by	the	National	Institute	for	Health	and	Welfare	(THL/546/5.05.00.2014),	the	Population	Register	Centre	(D1794/410/14),	and	Statistics	Finland	(Dnro	TK53-547-14).		
	
	
RESULTS		
All-cause	mortality		Altogether	2.5	million	person-years	(34%	in	the	endometriosis	cohort	and	66%	of	the	control	cohort)	of	follow-up	accumulated	during	the	mean	follow-up	time	of	16.8	(standard	deviation	[SD]	±7.3)	years.	The	mean	age	of	the	study	population	at	the	end	of	the	follow-up	was	53.6	(SD	±12.1)	years.	The	demographic	characteristics	of	endometriosis	and	reference	cohorts	are	shown	in	Table	I.	The	person-years,	number	of	deaths,	and	mortality	rates	for	the	entire	study	population	including	both	cohorts	are	shown	in	Supplementary	Table	SII	by	calendar	time	and	age.			There	were	altogether	1656	and	4291	deaths,	and	the	mortality	rate	was	19.6	and	25.9	per	1,000	women	over	ten	years	among	endometriosis	and	reference	cohorts.	Of	the	observed	deaths	in	the	endometriosis	cohort	817	(49%)	were	due	to	malignant	neoplasms,	277	(17%)	due	to	diseases	of	the	circulatory	system,	and	199	(12%)	due	to	accidents	and	violence.	For	both	cohorts,	the	number	of	deaths,	the	crude	all-cause	and	cause-specific	MRs	are	shown	in	Supplementary	Table	SIII.		
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	Table	II	shows	the	crude	and	adjusted	all-cause	and	cause-specific	MRRs	with	their	95%	CIs	from	the	Model	1	and	Model	2.	The	change	in	the	MRRs	after	additional	adjustment	for	live	births	was	minor	and	therefore,	the	“adjusted”	refers	here	to	Model	2.	In	the	endometriosis	cohort,	we	observed	a	lower	risk	of	all-cause	mortality	(adjusted	MRR	0.73	[95%	CI	0.67	to	0.77]).	The	adjusted	absolute	rate	difference	in	all-cause	mortality	was	-4.27	(95%	CI	-6.24	to	-2.30)	among	1000	women	over	ten	years	with	surgically	verified	endometriosis	compared	to	the	women	in	the	reference	cohort.			The	adjusted	relative	difference	in	all-cause	mortality	decreased	over	time	remaining,	however,	was	statististically	significant	24	years	(Figure	I).	Figure	II	illustrates	the	adjusted	MRRs	for	any	and	several	specific	causes	of	death.			
Cancer	mortality			The	mortality	rate	of	any	cancer	was	9.7	and	10.7	per	1,000	women	over	ten	years	among	the	endometriosis	and	reference	cohorts,	respectively.	The	adjusted	MRR	(0.88	[95%	CI	0.81	to	0.96])	showed	a	lower	mortality	due	to	any	cancer	in	the	endometriosis	cohort	as	compared	to	the	reference	cohort	(Table	II).	The	adjusted	absolute	rate	difference	of	death	due	to	any	cancer	was	-0.57	(95%	CI	-1.63	to	0.50)	per	1000	women	over	ten	years	between	the	endometriosis	and	reference	cohorts.			
Cardiovascular	mortality	
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The	mortality	rate	due	to	diseases	of	the	circulatory	system	was	3.3	and	5.5	per	1000	women	over	ten	years	among	the	endometriosis	and	reference	cohorts.	The	adjusted	MRR	(0.57	[95%	CI	0.50	to	0.65])	was	significantly	lower	in	the	endometriosis	than	in	the	reference	cohort,	and	this	difference	was	consistent	across	specific	diseases,	including	cardiovascular	diseases,	ischemic	heart	disease,	and	cerebrovascular	disease	(Table	II).	The	adjusted	absolute	rate	difference	was	-0.02	(95%	CI	-0.12	to	0.08)	per	1000	women	over	ten	years	between	the	endometriosis	and	reference	cohorts.		
Other	causes	of	mortality	
The	mortality	rate	due	to	alcohol-related	causes	(alcohol-related	diseases	and	accidental	poisoning	by	alcohol)	was	1.0	and	2.3	per	1000	women	over	ten	years	among	the	endometriosis	and	reference	cohorts	(adjusted	MRR	0.42	[95%	CI	0.33	to	0.53]).	Mortality	due	to	other	causes	of	death,	such	as	diseases	of	the	respiratory	and	digestive	systems,	accidents	and	violence	was	also	lower	in	the	endometriosis	cohort.	No	differences	in	mortality	were	found	to	be	due	to:	dementia	or	Alzheimer’s	disease	combined;	other	diseases	of	the	nervous	system	and	sense	organs;	or	suicide	(Table	II,	Figure	II).	
Sensitivity	analysis	
According	to	the	results	of	sensitivity	analysis	assessing	the	age-specific	relative	difference	in	all-cause	mortality	between	the	cohorts,	the	MRRs	were	consistent	
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across	the	entire	age	range	at	death	covered	by	the	study	except	the	youngest	age	group	(<30	years,	49	deaths	[Figure	III]).	The	results	of	sensitivity	analysis	according	to	the	status	of	baseline	gynecological	organ	removals	suggested	significant	differences	in	adjusted	MRR	only	with	breast	and	ovarian	cancer	(Supplementary	Table	SIV).		The	adjusted	MRR	of	breast	cancer	was	significantly	decreased	only	in	women	with	endometriosis	and	baseline	gynecological	organ	removals	as	compared	to	the	reference	population,	of	which	we	excluded	women	with	gynecological	organ	removals	before	or	at	the	index	date.	On	the	contrary,	the	MRR	of	ovarian	cancer	was	significantly	increased	only	in	women	without	gynecological	organ	removals	in	endometriosis	cohort	compared	to	the	women	in	the	reference	cohort	who	had	no	previous	gynecological	organ	removals.	In	all-cause	MRR,	or	in	MRR	due	to	cardiovascular	disease,	accidents	and	violence,	or	suicides	no	difference	was	seen.	 		
	
	
DISCUSSION		The	all-cause	mortality	in	midlife	was	lower	throughout	the	follow-up	among	women	with	surgically	verified	endometriosis	compared	to	the	reference	cohort.		The	absolute	difference	was	low	-	four	fewer	deaths	occurred	among	1000	women	over	ten	years	of	follow-up	in	endometriosis	patients.	Endometriosis	is	associated	with	an	increased	risk	of	several	common	diseases,	also	known	as	common	causes	of	death.	However,	even	if	morbidity	is	increased,	mortality	due	to	these	conditions	may	be	decreased.	Nevertheless,	even	after	adjustments	mortality	due	to	these	conditions	was	decreased,	i.e.	deaths	due	to	any	cancer	
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and	cardiovascular	conditions	including	ischemic	heart	disease	and	cerebrovascular	disease.	We	also	found	a	decreased	risk	of	death	due	to	alcohol-related	causes,	accidents	and	violence,	and	diseases	of	the	digestive	and	respiratory	system.	
	The	strengths	of	this	study	include	the	surgically	diagnosed	endometriosis	disease,	the	large,	population-based	cohort	of	women,	and	the	long	follow-up	(nearly	three	decades	of	calendar	time	and	a	follow-up	of	2.5	million	person-years).	Finland	has	a	long	history	of	administrative	data	collection.	Nationwide	health	and	social	registers	have	provided	an	important	data	source	for	epidemiological	research.	Moreover,	due	to	the	high-quality	nationwide	population-based	registers,	the	completeness	and	validity	of	the	data	are	reliable	(Gissler	and	Haukka,	2004,	Pukkala,	et	al.,	2017,	Sund,	2012).	The	registers	also	allowed	us	to	adjust	for	many	demographic	factors	that	are	important	when	assessing	mortality	(Forouzanfar,	et	al.,	2016,	Jensen,	et	al.,	2017,	Mackenbach,	et	al.,	2016,	Stringhini,	et	al.,	2017).	In	addition,	previous	knowledge	of	the	all-cause	and	cause-specific	mortality	in	women	with	endometriosis	is	scarce.		Several	important	lifestyle	factors,	such	as	smoking,	alcohol	consumption,	body	mass	index,	or	use	of	medications	could	not	be	adjusted	for	as	they	do	not	exist	in	our	register-based	data.	These	risk	factors	contribute	significantly	to	the	development	and	prognosis	of	several	illnesses,	and	therefore	also	to	deaths	–	therefore	the	residual	confounding	cannot	be	ruled	out	(Danaei,	et	al.,	2009,	Di	Angelantonio,	et	al.,	2016,	Flegal,	et	al.,	2013).	In	previous	studies,	endometriosis	diagnosis	has	been	associated	with	lower	body	mass	index,	but	the	results	have	
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been	inconsistent	for	alcohol	consumption	and	tobacco	smoking	(Parazzini,	et	al.,	2013,	Bravi,	et	al.,	2014,	Shafrir,	et	al.	2018).	We	found	lower	risk	of	death	due	to	alcohol-related	causes	in	women	diagnosed	with	endometriosis.	In	addition,	the	decreased	mortality	due	to	accidents	and	violence	might	also	reflect	the	safer	lifestyle	of	women	with	endometriosis.	However,	there	was	no	significant	difference	in	the	risk	of	lung	cancer	mortality,	which	often	reflects	the	smoking	habits	of	the	study	population.		The	present	study	may	also	be	subject	to	selection	bias,	bias	by	indication,	detection	bias	or	reverse	causality.	First,	the	selection	bias	exists	as	the	procedural	data	was	not	collected	until	1987	and	therefore,	some	women	in	the	reference	cohort	may	have	undergone	the	endometriosis	procedures	prior	to	that.	Moreover,	the	reference	cohort	is	likely	to	include	women	with	undiagnosed	endometriosis	(approx.	2%;	Zondervan,	et	al.,	2002)	and	endometriosis	without	surgical	verification.				Uneven	access	to	health	care	results	often	in	another	selection	bias.	There	are	also	some	inequalities	in	access	to	health	care	in	Finland	(Kangas	and	Blomgren,	2014).	Moreover,	the	access	to	the	specialized	medical	care	may	depend	on	patient’s	awareness	and	persistence.	This	may	cause	a	selection	bias	in	our	study.	In	the	analysis,	we	adjusted	for	the	education	level	that	is	known	to	be	associated	with	the	socioeconomic	status,	health	behavior	and	risk	contexts.	Endometriosis	is	typically	diagnosed	after	a	delay	of	approximately	seven	years	(Nnoaham,	et	al.,	2011).	Thus,	women	in	the	endometriosis	cohort	are	likely	to	have	been	rather	persistent	in	seeking	medical	advice	and	help.	This	may	apply	
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to	other	health	issues	as	well.		In	addition,	receiving	an	endometriosis	diagnosis	and	medical	attention	might	alter	the	overall	behavior	towards	healthier	lifestyle.	It	is	also	possible	that	some	of	the	important	risk	factors,	such	as	alcohol	abuse,	restrain	women	from	seeking	medical	help.	Moreover,	to	be	eligible	for	operative	treatment	is	likely	to	exclude	several	serious	conditions,	and	preoperative	evaluation	might	reveal	other	pre-existing	diseases	as	well	as	increased	medical	attention	postoperatively	leads	to	a	situation	referred	as	selection	and	detection	bias.			The	indication	bias	is	caused	by	limiting	the	study	cohort	to	women	with	endometriosis	eligible	for	operative	treatment,	although	the	indications	were	not	otherwise	limited	as	we	also	included	incidental	diagnosis	of	endometriosis	(subsidiary	diagnosis	35%	of	all	diagnosis).	In	addition,	confounding	by	indication	might	also	be	caused	by	the	presence	of	comorbidities	between	the	cohorts,	not	adjusted	in	the	present	study.		Moreover,	live	births	were	taken	into	account	as	nulliparous	women	are	known	to	have	increased	risk	of	death	(Zeng	et	al.,	2016).	However,	the	data	on	infertility	was	not	available.	Furthermore,	the	former	data	have	shown	women	with	assisted	reproductive	techniques	to	have	decreased	risk	of	death	although	the	recent	study	have	shown	that	there	is	a	healthy	patient	effect	-	the	risk	of	death	returns	to	normal	after	ten	years.	(Braat,	et	al.,	2010,	Vassard,	et	al.,	2018)		Women	with	endometriosis	are	likely	to	use	more	non-steroidal	anti-inflammatory	drugs	and	hormonal	medications	such	as	oral	contraceptives.	Non-
Saavalainen		
Endometriosis & Mortality	 	 	20	
steroidal	anti-inflammatory	drugs	are	known	to	decrease	the	risk	of	death	due	to	ovarian,	colon	and	breast	cancer	and	moreover,	also	the	deaths	due	to	myocardial	infarction	(Verdoodt,	et	al.,	2017,	Din,	et	al.,	2010,	Huang,	et	al.,	2015,	Olsen,	et	al.,	2011).	Furthermore,	oral	contraceptives	are	reported	to	decrease	the	overall	risk	of	death	and	for	example	deaths	due	to	ovarian	cancer	(Hannaford,	et	al.,	2010,	Beral,	et	al.,	2008).	The	use	of	these	medications	might	contribute	in	part	to	the	decreased	mortality	among	women	with	endometriosis.				
	Another	limitation	in	our	study	is	that	it	fails	to	reliably	extend	into	older	age	groups.	The	mean	age	when	entering	to	the	study	cohorts	was	36	years,	and	after	the	follow-up	was	53	years.	Therefore,	data	on	women	older	than	75	years	of	age	are	limited.	Many	diseases	have	their	highest	incidences	in	older	ages,	including	many	cancers,	dementia,	or	Alzheimer’s	disease	(Naghavi,	et	al.,	2017).	Thus,	our	results	can	only	be	generalized	to	midlife	women.			The	potential	presence	of	several	types	of	bias	may	explain	at	least	part	–	or	even	entire	–	of	the	lower	all-cause	mortality	seen	among	women	with	endometriosis.	A	difference	in	the	overall	mortality	between	the	cohorts	was	present	already	at	the	time	of	the	index	surgery	and	persisted	24	years.	This	suggests	the	difference	to	be	drawn	by	the	factors	other	than	endometriosis	per	se.	Thus,	the	present	results	can	be	applied	only	to	midlife	women	with	surgically	verified	endometriosis	and	caution	is	needed	when	interpreting	the	results	in	terms	of	causality.			
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During	the	study	period	the	two	most	common	causes	of	death	among	working	aged	Finnish	women	were	neoplasms	and	diseases	of	the	circulatory	system,	followed	by	causes	related	to	alcohol,	accidents,	and	suicides.	The	risk	of	death	due	to	any	cancer	was	decreased	among	women	with	surgically	verified	endometriosis.	After	adjustments	for	potential	confounders,	there	were	12%	fewer	cancer	deaths	in	the	endometriosis	cohort.	At	baseline	any	gynecological	organ	removal	(hysterectomy,	unilateral	or	bilateral	oophorectomy	or	both)	occurred	in	38%	of	the	endometriosis	cohort	and	3%	of	the	reference	cohort.	Even	though	these	procedures	cannot	be	separated	from	endometriosis	treatment,	they	account	partly	for	the	decreased	cancer	deaths.	Indeed,	the	sensitivity	analysis	showed	that	the	adjusted	MRR	for	ovarian	cancer	was	increased	only	in	women	with	endometriosis	who	had	no	baseline	gynecological	organ	removals.	In	addition	to	the	sensitivity	analyses,	the	proportion	of	the	association	between	endometriosis	and	mortality	explained	by	the	various	treatments	or	interventions	(including	organ	removal)	have	not	been	addressed	in	this	analysis.	As	morbidity	studies	to	date	suggest,	treatments,	and	in	particular	organ	removal,	may	play	an	important	role	on	the	causal	pathway(s).		The	association	of	endometriosis	and	favorable	prognosis	of	ovarian	cancer	has	been	reported	previously	(Melin,	et	al.,	2011,	Kim,	et	al.,	2014).	The	focus	of	the	present	study	was,	however,	on	the	mortality	in	women	with	endometriosis	as	followed	from	the	index	surgery	due	to	endometriosis	but	not	from	cancer	diagnosis.	Therefore,	the	results	of	our	study	cannot	be	interpreted	in	terms	of	cancer	survival.				
Saavalainen	
Endometriosis & Mortality	 22	
Mortality	due	to	breast	cancer	was	decreased	in	women	with	surgically	verified	endometriosis	compared	to	the	reference	cohort	before	and	after	adjustment	for	important	risk	factors,	such	as	parity.	Parity	and	breast	feeding	are	known	to	decrease	the	risk	of	breast	cancer	(Lambertini,	et	al.,	2016,	Victora,	et	al.,	2016).	Moreover,	the	risk	of	breast	cancer	and	breast	cancer	deaths	are	also	reduced	by	oophorectomy	(Nichols,	et	al.,	2011,	Parker,	et	al.,	2013).	The	sensitivity	analysis	included	all	gynecological	organ	removals	(hysterectomy	and/or	oophorectomy/-ies)	and	showed	that	only	women	with	gynecological	organ	removals	had	significantly	decreased	MRR	for	breast	cancer.	Hormonal	replacement	therapy,	or	the	lack	of	it,	might	affect	breast	cancer	mortality,	but	unfortunately,	we	lacked	data	on	the	possible	use	of	hormonal	replacement	therapy	in	our	study	cohort.	The	numbers	of	deaths	due	to	other	cancers	are	too	few	to	reliably	assess	the	possible	differences	associated	to	endometriosis.		
Compared	to	the	reference	cohort,	45%	fewer	deaths	due	to	cardiovascular	diseases	were	reported	for	women	with	surgically	verified	endometriosis.	This	finding	was	further	strengthened	following	disease	specific	calculations	for	ischemic	heart	disease	and	cerebrovascular	disease,	where	the	adjusted	risk	of	death	was	also	decreased.	Moreover,	in	the	sensitivity	analysis	gynecological	organ	removals	had	no	effect	on	the	difference.	Recent	studies	have	shown	that	oophorectomy	and	early	menopause	increase	the	mortality	for	cardiovascular	disease	(Evans,	et	al.,	2017,	Gong,	et	al.,	2016,	Muka,	et	al.,	2016,	Mytton,	et	al.,	2017).	In	addition,	in	a	recent	North	American	study	even	hysterectomy	without	oophorectomy	when	performed	to	women	aged	35	years	or	under	increases	the	risk	of	cardiovascular	conditions	(Laughlin-Tomaso,	et	al.,	2018).	However,	the	
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role	of	parity	or	hormonal	replacement	therapy	is	unclear	(Boardman,	et	al.,	2015,	Jacobs,	et	al.,	2012,	Magnus,	et	al.,	2017,	Santen,	et	al.,	2010,	Tuomikoski	and	Mikkola,	2014).	No	adjustments	were	made	in	this	study	for	the	major	cardiovascular	risk	factors	-	hypertension,	diabetes,	and	hypercholesterolemia	-	nor	for	lifestyle	factors,	due	to	the	unavailability	of	such	information	(Mosca,	et	al.,	2011).	The	decrease	in	cardiovascular	mortality	might	partly	relate	to	the	risk	factors.		Studies	with	longer	follow-up	times	are	likely	to	clarify	these	results	as	cardiovascular	diseases	occur	more	often	in	advanced	age.		Alzheimer’s	disease	has	been	linked	to	chronic	inflammation	(Nogueira,	et	al.,	2015).	However,	according	to	a	recent	Canadian	study	mortality	rate	due	to	Alzheimer’s	disease	in	women	increases	only	after	75	years	of	age	and	the	mean	age	at	death	is	86	years	(Park,	2016).		In	the	present	study,	the	mean	age	of	women	at	the	end	of	follow-up	was	54,	precluding	from	a	reliable	assessment	of	the	potential	relationship	between	endometriosis	and	Alzheimer’s	disease.			In	conclusion,	the	overall	mortality	in	midlife	was	lower	in	women	with	surgically	verified	endometriosis	when	compared	to	the	reference	cohort.	The	adjusted	cause-specific	mortality	due	to	cancer,	circulatory	diseases,	cardiovascular	diseases,	alcohol	related	causes,	accidents	and	violence,	and	diseases	of	the	digestive	and	respiratory	systems,	were	all	decreased.	We	speculate	that	the	decreased	mortality	is	significantly	due	to	different	characteristics	and	factors	related	to	women’s	lifestyle,	and/or	increased	medical	attention	and	care	received	among	women	with	surgically	verified	endometriosis.	There	is	a	need	for	more	studies	on	this	issue.	
Saavalainen	
Endometriosis & Mortality	 24	
AUTHORS’	ROLES		
All	authors	contributed	to	the	study	idea	and	planning	the	study	design.	The	data	linkages,	management	and	statistical	analyses	were	comprised	by	AB	and	JH.	The	interpretation	of	the	data	and	results	were	contributed	by	all	authors.	LS	drafted	the	article	in	supervision	by	OH.	All	authors	reviewed	and	revised	the	article	and	approved	the	final	version.		
FUNDING 
This	research	was	funded	by	the	Hospital	District	of	Helsinki	and	Uusimaa	and	The	Finnish	Medical	Foundation.		
CONFLICT OF INTEREST 
None. 
Saavalainen	
Endometriosis & Mortality	 25	
REFERENCES	1	 	2	 Beral	V,	Doll	R,	Hermon	C,	Peto	R,	Reeves	G,	Brinton	L,	Green	AC,	Marchbanks	P,	Negri	E,	Ness	R	et	3	
al.	 Ovarian	 cancer	 and	 oral	 contraceptives:	 collaborative	 reanalysis	 of	 data	 from	 45	4	 epidemiological	studies	including	23	257	women	with	ovarian	cancer	and	87	303	controls.	Lancet	5	 2008;371:	303-314.	6	 	7	 Boardman	HMP,	Hartley	L,	Eisinga	A,	Main	C,	Figuls	MRI,	Cosp	XB,	Sanchez	R,	Knight	B.	Hormone	8	 therapy	for	preventing	cardiovascular	disease	in	post-menopausal	women.	Cochrane	Database	of	9	
Systematic	Rev	2015;3:	CD002229.	10	 	11	 Braat	DDM,	Schutte	JM,	Bernardus	RE,	Mooij	TM,	van	Leeuwen	FE.	Maternal	death	related	to	IVF	12	 in	the	Netherlands	1984-2008.	Human	Reproduction	2010;25:	1782-1786.	13	 	14	 Bravi	F,	Parazzini	F,	Cipriani	S,	Chiaffarino	F,	Ricci	E,	Chiantera	V,	Vigano	P,	La	Vecchia	C.	Tobacco	15	 smoking	 and	 risk	 of	 endometriosis:	 a	 systematic	 review	 and	meta-analysis.	BMJ	Open	 2014;4:	16	 e006325.	17	 	18	 Danaei	G,	Ding	EL,	Mozaffarian	D,	Taylor	B,	Rehm	J,	Murray	CJL,	Ezzati	M.	The	Preventable	Causes	19	 of	Death	in	the	United	States:	Comparative	Risk	Assessment	of	Dietary,	Lifestyle,	and	Metabolic	20	 Risk	Factors.	PloS	Med	2009;6:	e1000058	21	 	22	 Di	Angelantonio	E,	 Bhupathiraju	SN,	Wormser	D,	Gao	P,	 Kaptoge	 S,	 de	Gonzalez	AB,	Cairns	BJ,	23	 Huxley	 R,	 Jackson	 CL,	 Joshy	 G	 et	 al.	 Body-mass	 index	 and	 all-cause	 mortality:	 individual-24	 participant-data	meta-analysis	of	239	prospective	studies	 in	 four	continents.	Lancet	2016;388:	25	 776-786.	26	 	27	 Din	FVN,	Theodoratou	E,	Farrington	SM,	Tenesa	A,	Barnetson	RA,	Cetnarskyj	R,	Stark	L,	Porteous	28	 ME,	Campbell	H,	Dunlop	MG.	Effect	of	aspirin	and	NSAIDs	on	risk	and	survival	 from	colorectal	29	 cancer.	Gut	2010;59:	1670-1679.	30	 	31	 Evans	EC,	Matteson	KA,	Orejuela	FJ,	Alperin	M,	Balk	EM,	El-Nashar	S,	Gleason	JL,	Grimes	C,	Jeppson	32	 P,	Mathews	C	 et	al.	 Salpingo-oophorectomy	at	 the	Time	of	Benign	Hysterectomy:	A	Systematic	33	 Review.	Obstet	Gynecol	Survey	2017;72:	220-223.	34	 	35	 Flegal	KM,	Kit	BK,	Orpana	H,	Graubard	BI.	Association	of	All-Cause	Mortality	With	Overweight	and	36	 Obesity	Using	Standard	Body	Mass	Index	Categories	A	Systematic	Review	and	Meta-analysis.	JAMA	37	 2013;309:	71-82.	38	39	
Saavalainen	
Endometriosis & Mortality	 26	
Forouzanfar	MH,	Afshin	A,	Alexander	LT,	Anderson	HR,	Bhutta	ZA,	Biryukov	S,	Brauer	M,	Burnett	40	 R,	 Cercy	K,	Charlson	 FJ	 et	 al.	Global,	 regional,	 and	national	 comparative	 risk	assessment	 of	 79	41	 behavioural,	environmental	and	occupational,	and	metabolic	risks	or	clusters	of	risks,	1990-2015:	42	 a	systematic	analysis	for	the	Global	Burden	of	Disease	Study	2015.	Lancet	2016;388:	1659-1724.	43	 	44	 Gissler	M,	Haukka	J.	Finnish	health	and	social	welfare	registers	in	epidemiological	research.	Norsk	45	
Epidemiologi	2004;14:	113-120.	46	 	47	 Gong	DD,	Sun	J,	Zhou	YJ,	Zou	C,	Fan	Y.	Early	age	at	natural	menopause	and	risk	of	cardiovascular	48	 and	 all-cause	 mortality:	 A	 meta-analysis	 of	 prospective	 observational	 studies.	 Int	 J	 Cardiol	49	 2016;203:	115-119.	50	 	51	 Gordon	M,	Lumney	T.	Forestplot:	Advanced	Forest	Plot	Using	‘grid’	Graphics.	2017.	https://cran.r-52	 project.org/web/packages/forestplot/forestplot.pdf.	53	 	54	 Hannaford	PC,	Iversen	L,	Macfarlane	TV,	Elliott	AM,	Angus	V,	Lee	AJ.	Mortality	among	contraceptive	55	 pill	users:	cohort	evidence	from	Royal	College	of	General	Practitioners'	Oral	Contraception	Study.	56	
British	Medical	Journal	2010;340:	c927.	57	 	58	 Huang	XZ,	Gao	P,	Sun	JX,	Song	YX,	Tsai	CC,	Liu	J,	Chen	XW,	Chen	P,	Xu	HM,	Wang	ZN.	Aspirin	and	59	 nonsteroidal	anti-inflammatory	drugs	after	but	not	before	diagnosis	are	associated	with	improved	60	 breast	cancer	survival:	a	meta-analysis.	Cancer	Causes	&	Control	2015;26:	589-600.	61	 	62	 Jacobs	MB,	Kritz-Silverstein	D,	Wingard	DL,	Barrett-Connor	E.	 The	 association	 of	 reproductive	63	 history	with	all-cause	and	cardiovascular	mortality	in	older	women:	the	Rancho	Bernardo	Study.	64	
Fertil	Steril	2012;97:	118-124.	65	 	66	 Jensen	 NL,	 Pedersen	 HS,	 Vestergaard	 M,	 Mercer	 SW,	 Glumer	 C,	 Prior	 A.	 The	 impact	 of	67	 socioeconomic	 status	 and	 multimorbidity	 on	 mortality:	 a	 population-based	 cohort	 study.	 Clin	68	
Epidemiol	2017;9:	279-289.	69	
 70	 Kangas	O,	Blomgren	J.	Socio-economic	differencies	in	health,	income	inequality,	unequal	access	to	71	 care	and	spending	on	health:	A	country-level	comparison	of	Finland	and	16	other	European	72	 countries.	Research	on	Finnish	Society	2014;7:51-63.	73	 	74	 Kim	 HS,	 Kim	 TH,	 Chung	 HH,	 Song	 YS.	 Risk	 and	 prognosis	 of	 ovarian	 cancer	 in	 women	 with	75	 endometriosis:	a	meta-analysis.	Br	J	Cancer	2014;110:	1878-1890.	76	77	
Saavalainen		
Endometriosis & Mortality	 	 	27	
Kvaskoff	M,	Mu	F,	Terry	KL,	Harris	HR,	Poole	EM,	Farland	L,	Missmer	SA.	Endometriosis:	a	high-78	 risk	population	for	major	chronic	diseases?	Hum	Reprod	Update	2015;21:	500-516.	79	 	80	 Lambertini	M,	Santoro	L,	Del	Mastro	L,	Nguyen	B,	Livraghi	L,	Ugolini	D,	Peccatori	FA,	Azim	HA.	81	 Reproductive	 behaviors	 and	 risk	 of	 developing	 breast	 cancer	 according	 to	 tumor	 subtype:	 A	82	 systematic	review	and	meta-analysis	of	epidemiological	studies.	Cancer	Treat		Rev	2016;49:	65-76.	83	 	84	 Laughlin-Tommaso	SK,	Khan	Z,	Weaver	AL,	Smith	CY,	Rocca	WA,	Stewart	EA.	Cardiovascular	and	85	 metabolic	morbidity	after	hysterectomy	with	ovarian	conservation:	a	cohort	study.	Menopause-the	86	
Journal	of	the	North	American	Menopause	Society	2018;25:	483-492.	87	 	88	 Lozano	R,	Naghavi	M,	Foreman	K,	Lim	S,	Shibuya	K,	Aboyans	V,	Abraham	J,	Adair	T,	Aggarwal	R,	89	 Ahn	SY	et	al.	Global	and	regional	mortality	from	235	causes	of	death	for	20	age	groups	in	1990	and	90	 2010:	a	systematic	analysis	for	the	Global	Burden	of	Disease	Study	2010.	Lancet	2012;380:	2095-91	 2128.	92	 	93	 Mackenbach	JP,	Kulhanova	I,	Artnik	B,	Bopp	M,	Borrell	C,	Clemens	T,	Costa	G,	Dibben	C,	Kalediene	94	 R,	Lundberg	O	et	al.	Changes	in	mortality	inequalities	over	two	decades:	register	based	study	of	95	 European	countries.	BMJ	2016;353:i1732.	96	 	97	 Magnus	MC,	Iliodromiti	S,	Lawlor	DA,	Catov	 JM,	Nelson	SM,	Fraser	A.	Number	of	Offspring	and	98	 Cardiovascular	 Disease	 Risk	 in	Men	 and	Women	 The	Role	 of	 Shared	 Lifestyle	 Characteristics.	99	
Epidemiol	2017;28:	880-888.	100	 	101	 Melin	A,	Lundholm	C,	Malki	N,	Swahn	ML,	Sparen	P,	Bergqvist	A.	Endometriosis	as	a	prognostic	102	 factor	for	cancer	survival.	Int	J	Cancer	2011;129:	948-955.	103	 	104	 Mosca	 L,	 Barrett-Connor	 E,	 Wenger	 NK.	 Sex/Gender	 Differences	 in	 Cardiovascular	 Disease	105	 Prevention	What	a	Difference	a	Decade	Makes.	Circulation	2011;124:	2145-2154.	106	 	107	 Mu	F,	Rich-Edwards	J,	Rimm	EB,	Spiegelman	D,	Missmer	SA.	Endometriosis	and	Risk	of	Coronary	108	 Heart	Disease.	Circulation-Cardiovascular	Quality	and	Outcomes	2016;9:	257-264.	109	 	110	 Muka	T,	Oliver-Williams	C,	Kunutsor	S,	Laven	JSE,	Fauser	B,	Chowdhury	R,	Kavousi	M,	Franco	OH.	111	 Association	of	Age	at	Onset	of	Menopause	and	Time	Since	Onset	of	Menopause	With	Cardiovascular	112	 Outcomes,	Intermediate	Vascular	Traits,	and	All-Cause	Mortality	A	Systematic	Review	and	Meta-113	 analysis.	JAMA	Cardiol	2016;1:	767-776.	114	 	115	
Saavalainen		
Endometriosis & Mortality	 	 	28	
Mytton	J,	Evison	F,	Chilton	PJ,	Lilford	RJ.	Removal	of	all	ovarian	tissue	versus	conserving	ovarian	116	 tissue	at	time	of	hysterectomy	in	premenopausal	patients	with	benign	disease:	study	using	117	 routine	data	and	data	linkage.	BMJ	2017;356:	j372	118	 	119	 Naghavi	M,	Abajobir	AA,	Abbafati	C,	Abbas	KM,	Abd-Allah	F,	Abera	SF,	Aboyans	V,	Adetokunboh	O,	120	 Arnlov	J,	Afshin	A	et	al.	Global,	regional,	and	national	age-sex	specific	mortality	for	264	causes	of	121	 death,	 1980-2016:	 a	 systematic	 analysis	 for	 the	 Global	 Burden	 of	 Disease	 Study	 2016.	 Lancet	122	 2017;390:	1151-1210.	123	 	124	 Nichols	HB,	Visvanathan	K,	Newcomb	PA,	Hampton	JM,	Egan	KM,	Titus-Ernstoff	L,	Trentham-Dietz	125	 A.	Bilateral	Oophorectomy	in	Relation	to	Risk	of	Postmenopausal	Breast	Cancer:	Confounding	by	126	 Nonmalignant	Indications	for	Surgery?	Am	J	Epidemiol	2011;173:	1111-1120.	127	 	128	 Nnoaham	KE,	Hummelshoj	L,	Webster	P,	d'Hooghe	T,	Nardone	FdC,	Nardone	CdC,	 Jenkinson	C,	129	 Kennedy	SH,	Zondervan	KT,	Women's	Hlth	C.	Impact	of	endometriosis	on	quality	of	life	and	work	130	 productivity:	a	multicenter	study	across	ten	countries.	Fertil	Steril	2011;96:	366-373.	131	 	132	 Nogueira	ML,	Moreira	JdV,	Baronzio	GF,	Dubois	B,	Steyaert	J-M,	Schwartz	L.	Mechanical	stress	as	133	 the	common	denominator	between	chronic	inflammation,	cancer,	and	Alzheimer's	disease.	Front	134	
Oncol	2015;5:	197-197.	135	 	136	 Olsen	AMS,	Fosbol	EL,	Lindhardsen	J,	Folke	F,	Charlot	M,	Selmer	C,	Lamberts	M,	Olesen	JB,	Kober	L,	137	 Hansen	PR	et	al.	Duration	of	Treatment	With	Nonsteroidal	Anti-Inflammatory	Drugs	and	Impact	138	 on	Risk	of	Death	and	Recurrent	Myocardial	Infarction	in	Patients	With	Prior	Myocardial	Infarction	139	 A	Nationwide	Cohort	Study.	Circulation	2011;123:	2226-2235.	140	 	141	 Parazzini	F,	Cipriani	S,	Bravi	F,	Pelucchi	C,	Chiaffarino	F,	Ricci	E,	Vigano	P.	A	meta-analysis	on	142	 alcohol	consumption	and	risk	of	endometriosis.	Am	J	Obstet	Gynecol	2013;209:106.e1-10.	143	 	144	 Park	J.	Mortality	from	Alzheimer's	disease	in	Canada:	A	multiple-cause-of-death	analysis,	2004	to	145	 2011.	Health	Reports	2016;27:	17-21.	146	 	147	 Parker	WH,	Feskanich	D,	Broder	MS,	Chang	E,	Shoupe	D,	Farquhar	CM,	Berek	JS,	Manson	JE.	Long-148	 Term	 Mortality	 Associated	With	 Oophorectomy	 Compared	 With	 Ovarian	 Conservation	 in	 the	149	 Nurses'	Health	Study.	Obstet	Gynecol	2013;121:	709-716.	150	 	151	 Plummer	M,	Carstensen	B.	Lexis:	An	R	Class	for	Epidemiological	Studies	with	Long-Term	Follow-152	 Up.	J	Stat	Soft		2011;38:1-12.	153	 	154	
Saavalainen	
Endometriosis & Mortality	 29	
Pukkala	 E,	 Engholm	 G,	 Højsgaard	 S,	 Schmidt	 LK,	 Strom	 H,	 Khan	 S,	 Lambe	 M,	 Pettersson	 D,	155	 Ólafsdóttir	E,	Tryggvadóttir	L	et	al.	Nordic	Cancer	Registries	-	an	overview	of	their	procedures	and	156	 data	comparability.	Acta	Oncol	2018;	57:440-455	157	 	158	 Saavalainen	L,	Tikka	T,	But	A,	Gissler	M,	Haukka	J,	Tiitinen	A,	Harkki	P,	Heikinheimo	O.	Trends	in	159	 the	incidence	rate,	type	and	treatment	of	surgically	verified	endometriosis	-	a	nationwide	cohort	160	 study.	Acta	Obstetr	Gynecol	Scand	2018;97:	59-67.	161	 	162	 Shafrir	AL,	Farland	LV,	Shah	DK,	Harris	HR,	Kvaskoff	M,	Zondervan	K,	Missmer	SA.	Risk	for	and	163	 consequences	of	endometriosis:	A	critical	epidemiologic	review.	Best	Practice	&	Research	Clinical	164	
Obstetrics	&	Gynaecology	2018;51:	1-15.	165	 	166	 Santen	RJ,	Allred	DC,	Ardoin	SP,	Archer	DF,	Boyd	N,	Braunstein	GD,	Burger	HG,	Colditz	GA,	Davis	167	 SR,	 Gambacciani	 M	 et	 al.	 Postmenopausal	 Hormone	 Therapy:	 An	 Endocrine	 Society	 Scientific	168	 Statement.	J	Clin	Endocrinol	Metab	2010;95:	S1-S66.	169	 	170	 Simoens	 S,	Dunselman	G,	Dirksen	C,	Hummelshoj	 L,	 Bokor	A,	 Brandes	 I,	 Brodszky	V,	 Canis	M,	171	 Colombo	GL,	DeLeire	T	et	al.	The	burden	of	endometriosis:	costs	and	quality	of	life	of	women	with	172	 endometriosis	and	treated	in	referral	centres.	Hum	Reprod	2012;27:	1292-1299.	173	 	174	 Stringhini	S,	Carmeli	C,	Jokela	M,	Avendano	M,	Muennig	P,	Guida	F,	Ricceri	F,	d'Errico	A,	Barros	H,	175	 Bochud	M	et	al.	Socioeconomic	status	and	the	25	x	25	risk	factors	as	determinants	of	premature	176	 mortality:	a	multicohort	study	and	meta-analysis	of	1.7	million	men	and	women.	Lancet	2017;389:	177	 1229-1237.	178	 	179	 Sund	R.	Quality	of	 the	Finnish	Hospital	Discharge	Register:	A	systematic	 review.	Scand	 J	Public	180	
Health	2012;40:	505-515.	181	 	182	 Tuomikoski	P,	Mikkola	TS.	Postmenopausal	hormone	therapy	and	coronary	heart	disease	in	early	183	 postmenopausal	women.	Ann	Med	2014;46:	1-7.	184	 	185	 Vassard	D,	Schmidt	L,	Pinborg	A,	Petersen	GL,	Forman	JL,	Hageman	I,	Glazer	CH,	Kamper-Jorgensen	186	 M.	Mortality	in	Women	Treated	With	Assisted	Reproductive	Technology-Addressing	the	Healthy	187	 Patient	Effect.	American	Journal	of	Epidemiology	2018;187:	1889-1895.	188	 	189	 Verdoodt	 F,	 Kjaer	 SK,	 Friis	 S.	 Influence	 of	 aspirin	 and	non-aspirin	 NSAID	 use	 on	 ovarian	 and	190	 endometrial	cancer:	Summary	of	epidemiologic	evidence	of	cancer	risk	and	prognosis.	Maturitas	191	 2017;100:	1-7.	192	193	
Saavalainen	
Endometriosis & Mortality	 30	
Vercellini	P,	Vigano	P,	Somigliana	E,	Fedele	L.	Endometriosis:	pathogenesis	and	treatment.	Nat	Rev	194	
Endocrinol	2014;10:	261-275.	195	 Victora	CG,	Bahl	R,	Barros	AJD,	Franca	GVA,	Horton	S,	Krasevec	J,	Murch	S,	Sankar	MJ,	Walker	N,	196	 Rollins	NC	et	al.	Breastfeeding	in	the	21st	century:	epidemiology,	mechanisms,	and	lifelong	effect.	197	
Lancet	2016;387:	475-490.	198	 	199	 Zeng	Y,	Ni	ZM,	Liu	SY,	Gu	X,	Huang	Q,	Liu	JA,	Wang	Q.	Parity	and	All-cause	Mortality	in	Women	and	200	 Men:	A	Dose-Response	Meta-Analysis	of	Cohort	Studies.	Scientific	Reports	2016;6:	19351.	201	 	202	 Zondervan	KT,	Cardon	LR,	Kennedy	SH.	What	makes	a	good	case-control	study?	Design	issues	for	203	 complex	traits	such	as	endometriosis.	Human	Reproduction	2002;17:	1415-1423.	204	
Saavalainen	
Endometriosis & Mortality	 31	
Table	I.	Baseline	characteristics	of	the	women	in	the	cohort	of	surgically	verified	endometriosis	and	in	the	reference	cohort.		209	
Endometriosis	
cohorta)
n	(%)	
Reference	
cohort	
n	(%)	
Characteristic	 (n=49	956)	 (n=98	824)	Year	of	entry	in	the	cohort	 				1987-1995	(ICD-9)	 23	655	(47.4)	 46	867	(47.4)					1996-2012	(ICD-10)	 26	301	(52.7)	 51	957	(52.6)	Age	at	entry	in	the	cohort	years	median	(IQR)					1987-1995	 38.6	(31.5,	44.1)	 38.6	(31.5,	44.1)					1996-2003	 35.1	(28.7,	43.3)	 35.1	(28.7,	43.3)					2004-2012	 33.4	(28.2,	41.1)	 33.4	(28.2,	41.1)	Age	at	entry	in	the	cohort	 				12-19	 526	(1.1)	 1053	(1.1)					20-29	 12	690	(25.4)	 25	152	(25.5)					30-39	 18	044	(36.1)	 35	599	(36.0)					40-49	 15	287	(30.6)	 30	260	(30.6)					50-59	 2984	(6.0)	 5918	(6.0)					60-69	 339	(0.7)	 670	(0.7)					70-79	 74	(0.1)	 148	(0.2)					80-85	 12	(0.0)	 24	(0.0)	Residenceb)	 				Urban	municipality	 34	161	(68.4)	 67	613	(68.4)					Densely	populated	 8540	(17.1)	 16	861	(17.1)					Rural	 7255	(14.5)	 14	350	(14.5)	Profession	at	baselinec)	 				Managers	 333	(2.1)	 535	(1.7)					Professionals	 2632	(16.6)	 4498	(14.4)					Technicians	 3005	(19.0)	 4891	(15.6)					Clerical	 1555	(9.8)	 2791	(8.9)					Service	and	sales	workers	 3296	(20.8)	 6131	(19.6)					Skilled	agricultural,	forestry						and	fishery	workers	 219	(1.4)	 522	(1.7)					Craft	and	related	trades	workers		 254	(1.6)	 466	(1.5)					Plant	and	machine	operators,	assemblers	 493	(3.1)	 912	(2.9)					Elementary	occupations	 825	(5.2)	 1760	(5.6)					Armed	forces	 6	(0.0)	 8	(0.0)					Unknown	 229	(1.5)	 550	(1.8)					Student,	pensioner	or	unemployed	 2511	(15.9)	 6052	(19.3)					Missing	 471	(3.0)	 2208	(7.1)	Socioeconomic	statusc)	 				Self-employed	 711	(4.5)	 1658	(5.3)					Upper-level	employees	 2972	(18.8)	 5302	(17.0)					Lower-level	employees	 6830	(43.2)	 12	018	(38.4)					Manual	workers	 2455	(15.5)	 5222	(16.7)					Students	 922	(5.8)	 2385	(7.6)					Pensioners	 346	(2.2)	 1039	(3.3)					Unemployed	 1243	(7.9)	 2628	(8.4)					Unknown	 320	(2.0)	 1011	(3.2)					Missing	 0	(0)	 0(0)	Highest	educationd)				Academic	 12	519	(25.1)	 23	341	(23.7)					Doctoral	 592	(1.2)	 1066	(1.1)					Master	 6147	(12.3)	 11	411	(11.6)					Bachelor	 5780	(11.6)	 10	864	(11.0)				Short-cycle	tertiary	 9870	(19.8)	 17	586	(17.8)				Upper	secondary	 19	140	(38.3)	 38	934	(39.4)				Primary	 8427	(16.9)	 18	963	(19.2)	
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				Primary	 7654	(15.3)	 16	721	(16.9)													Unknown	 773	(1.6)	 2242	(2.3)	Any	gynecological	organ	removal	at	index	day	or	before	 18	869	(37.8)	 2955	(3.0)					Hysterectomy	 5456	(10.9)	 1931	(2.0)					Unilateral	or	bilateral	oophorectomy	 	4303	(8.6)	 415	(0.0)					Hysterectomy	with	unilateral	or	bilateral							oophorectomy	 9110	(18.2)	 609	(0.1)	History	of	live	birth	at	baseline	 24	524	(49.1)	 67	218	(68.0)	ICD,	International	Classifications	of	Diseases.	IQR,	Interquartile	range.	a) Surgically	verified	endometriosis.b)	Determined	in	Statistics	Finland:	Urban,	city;	densely	populated,	area	where	200	people	ormore	are	living	nearby;	rural,	under	200	people	living	nearby,	usually	over	200	metres	between	213	 the	buildings.	214	 c	)Those	of	working	age	18-64	entering	to	the	cohort	during	1995,	2000,	2004-2012.	d)	The	highest	education	level	according	to	statistics	of	2014.
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Table	II.	MRR	for	endometriosis	versus	the	reference	cohort:	number	of	deaths	in	endometriosis	cohort	and	the	crude	and	the	adjusted	MRRs	in	women	with	endometriosis	compared	to	the	reference	cohort	with	their	95%	CI	per	10	000	person-years.		
Cause	of	death	
Deaths	in	
endometriosis	
cohort	(n)	
Crude	MRR		
(95%	CI)	
Adjusted	MRR		
(95%	CI),		
Model	1	
Adjusted	MRR		
(95%	CI),	
	Model	2	
All	causes	 1	656	 0.76	(0.72-0.80)	 0.77	(0.72-0.81)	 0.73	(0.69-0.77)				Malignant	neoplasms	 817	 0.91	(0.83-0.98)	 0.91	(0.84-0.99)	 0.88	(0.81-0.96)	Stomach		 40	 0.98	(0.67-1.44)	 0.99	(0.68-1.45)	 0.96	(0.66-1.41)	Colorectal	 76	 1.12	(0.85-1.49)	 1.13	(0.86-1.50)	 1.11	(0.84-1.47)	Pancreas	 51	 0.76	(0.55-1.05)	 0.76	(0.55-1.05)	 0.75	(0.54-1.03)	Trachea,	bronchus,	lung	 103	 1.04	(0.82-1.33)	 1.06	(0.84-1.35)	 1.06	(0.84-1.35)	Breast	 198	 0.84	(0.71-0.99)	 0.83	(0.71-0.98)	 0.81	(0.68-0.95)	Uterus	 20	 0.70	(0.42-1.17)	 0.69	(0.41-1.14)	 0.61	(0.37-1.03)	Ovary	 77	 1.09	(0.82-1.44)	 1.09	(0.82-1.44)	 1.01	(0.77-1.34)				Dementia	and	Alzheimer’s	disease	 47	 1.47	(1.01-2.14)	 1.43	(0.98-2.09)	 1.39	(0.95-2.03)				Other	diseases	of	the	nervous	system				and	sense	organs	 60	 0.94	(0.69-1.27)	 0.94	(0.69-1.27)	 0.87	(0.64-1.18)				Diseases	of	the	circulatory	systema)		 277	 0.60	(0.52-0.68)	 0.60	(0.53-0.69)	 0.57	(0.50-0.65)		Cardiovascular	diseases	 205	 0.58	(0.50-0.68)	 0.59	(0.50-0.69)	 0.55	(0.47-0.65)					Ischemic	heart	diseases	 115	 0.55	(0.45-0.68)	 0.56	(0.45-0.69)	 0.52	(0.42-0.64)					Cerebrovascular	diseases	 90	 0.63	(0.50-0.80)	 0.63	(0.50-0.80)	 0.60	(0.47-0.76)				Diseases	of	the	respiratory	system		 31	 0.43	(0.29-0.63)	 0.44	(0.30-0.65)	 0.42	(0.29-0.63)				Diseases	of	the	digestive	systema)	 29	 0.62	(0.41-0.94)	 0.63	(0.42-0.96)	 0.59	(0.39-0.90)				Alcohol	related	diseases					and	accidental	poisoning	by	alcohol	 82	 0.43	(0.34-0.54)	 0.44	(0.35-0.56)	 0.42	(0.33-0.53)				Accidents	and	violence	b)		 219	 0.85	(0.72-1.00)	 0.87	(0.74-1.02)	 0.80	(0.68-0.94)								Accidents	totalb)	 92	 0.72	(0.57-0.91)	 0.73	(0.58-0.93)	 0.68	(0.54-0.87)								Suicides	and	sequalae			of	intentional	self-harm	 114	 1.07	(0.85-1.35)	 1.10	(0.87-1.38)	 1.00	(0.79-1.26)				Other	causesc)	 48	 0.61	(0.44-0.84)	 0.63	(0.45-0.86)	 0.55	(0.40-0.77)	a)	Excluding	diseases	caused	by	alcohol.	b)	Excluding	accidental	poisonings	by	alcohol.	c)	Diseases	not	included	in	other	categories.Results	presented	when	number	of	deaths	exceeded	twenty	per	specific	death	cause.	The	adjustable	variables	used	in	multivariable	Poisson	analysis:	Model	1:	Adjusted	for	the	calendar	time	(ICD-9	or	ICD-10)	at	baseline,	the	highest	educational	level	(four	levels),	and	the	age	and	time-on-study	as	time	dependent	covariates	modelled	by	cubic	spline.		Model	2:	Model	1	variables	and	in	addition	live	births	as	time	dependent	dichotomous	(no/yes)	variable.	
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